Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01939652
Other study ID # UKCTUZLA
Secondary ID
Status Completed
Phase Phase 0
First received July 19, 2013
Last updated September 5, 2013
Start date February 2009
Est. completion date July 2013

Study information

Verified date September 2013
Source University Clinical Center Tuzla
Contact n/a
Is FDA regulated No
Health authority Bosnia: Federal Ministry of Health
Study type Interventional

Clinical Trial Summary

Elective minilaparatomy abdominal aortic aneurysm (AAA) repair is associated with a significant number of complications involving respiratory, cardiovascular, gastrointestinal and central nervous system, and mortality ranging up to 5%. In our study, we tested the hypothesis that intraoperative and postoperative intravenous restrictive fluid regime reduces postoperative morbidity and mortality and improves the outcome of the treatment of minilaparotomy AAA repair.


Description:

We investigate effects of a restricted fluid regime versus standard regimen on complications and hospital stay after minilaparatomy aortic aneurysm repair.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date July 2013
Est. primary completion date July 2013
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:

- AAA more than 5,5 cm in diameter tube graft

Exclusion Criteria:

- emargency comorbidity maligancy

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Intervention

Procedure:
Restrictive VS Standard Fluid Regime

Drug:
Drag: Crystalloids and Colloids


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
University Clinical Center Tuzla

Outcome

Type Measure Description Time frame Safety issue
Primary Number of major and minor complications 30 days Yes
Secondary ICU and duration of Hospital stay 30 days Yes
Secondary In-hospital mortality, 30-days mortality 30 days Yes
Secondary Fluid balance (daily and cumulative) 3 days Yes